Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add filters








Year range
1.
Biocell ; 29(3): 303-311, Aug.-Dec. 2005. ilus, graf
Article in English | LILACS | ID: lil-633237

ABSTRACT

TNFa has been associated with both, tumor survival and apoptosis. This cytokine is also involved in promoting cell migration during wound healing and tumorigenesis. SW756 is a HPV18-positive cervical carcinoma cell line, which has been used to study different mechanisms of cervical cancer progression. An in vitro assay of scratch wound healing onto monolayers of SW756 cells was used to assess the effect of TNFa on cell migration into a wound space. It was found that SW756 cells have the ability to migrate, but not proliferate in response to scratch wounding in a serum-free medium supplemented with TNFa. RT-PCR analysis showed that SW756 cells express TNFa mRNA when incubated in medium with and without serum. Wound closure and migration rate of SW756 cells were significantly increased in the presence of serum-free media supplemented with TNFa (10 ng/mL) as compared to serum-free media, and media supplemented with either anti-TNFa antibody or both TNFa and anti-TNFa antibody (p<0.05). The results showed a stimulatory effect of TNFa on the migration of SW756 cervical carcinoma cells, suggesting a novel and important role for TNFa in cervical cancer progression.


Subject(s)
Female , Humans , Carcinoma/microbiology , Cell Movement/drug effects , /genetics , Tumor Necrosis Factor-alpha/pharmacology , Uterine Cervical Neoplasms/microbiology , Cell Line, Tumor , Culture Media, Serum-Free , Carcinoma/genetics , Carcinoma/pathology , Cell Proliferation/drug effects , /isolation & purification , Image Processing, Computer-Assisted , Kinetics , Microscopy, Video , Reverse Transcriptase Polymerase Chain Reaction , RNA, Messenger/metabolism , Recombinant Proteins/drug effects , Uterine Cervical Neoplasms/genetics , Wound Healing/drug effects
2.
Biocell ; 28(1): 1-11, Apr. 2004.
Article in English | LILACS | ID: lil-384233

ABSTRACT

Birth is the result of complex, well-defined, and coordinated events, that are tightly regulated by endocrine, nervous, and immune responses, and take place primarily in the female reproductive tract. Various mechanisms and mediators involved in pregnancy, labor, and delivery, are highly conserved among different mammalian species and mast cells emerge as potential and crucial participants in these processes, as it is discussed in this review.


Subject(s)
Humans , Female , Pregnancy , Mast Cells/metabolism , Parturition/physiology , Uterus/metabolism , Muscle Contraction/physiology , Corticotropin-Releasing Hormone/metabolism , Gonadal Steroid Hormones/metabolism , Mast Cells/cytology , Muscle, Smooth/physiology , Oxytocin/metabolism , Uterus/cytology
3.
Biocell ; 27(2): 163-172, Aug. 2003.
Article in English | LILACS | ID: lil-384247

ABSTRACT

The purpose of this review, based on studies from our laboratory as well as from others, is to summarize salient features of mast cell immunobiology and to describe their associations with gastrointestinal mucosal defense. Gastrointestinal mast cells are involved in many pathologic effects, such as food hypersensitivity. On the other hand, they also play a protective role in defense against parasitic and microbial infections. Thus, they have both positive and negative effects, but presently the mechanisms that control the balance of these various effects are poorly known. It has been suggested that stabilization of mast cells may be a key mechanism to protect the gastrointestinal tract from injury. Few molecules are known to possess both mast cell stabilizing and gastrointestinal cytoprotective activity. These include zinc compounds, sodium cromoglycate, FPL 52694, ketotifen, aloe vera, certain flavonoids such as quercetin, some sulfated proteoglycans such as chondroitin sulfate and dehydroleucodine. Dehydroleucodine, a sesquiterpene lactone isolated from Artemisia douglasiana Besser, exhibits anti-inflammatory and gastrointestinal cytoprotective action. The lactone stimulates mucus production, and inhibits histamine and serotonin release from intestinal mast cells. The lactone could act as a selective mast cell stabilizer by releasing cytoprotective factors and inhibiting pro-inflammatory mast cell mediators.


Subject(s)
Humans , Digestive System , Mast Cells/cytology , Mast Cells/immunology , Anti-Inflammatory Agents , Immunity, Mucosal/immunology , Inflammation/drug therapy , Inflammation/immunology , Inflammation/physiopathology , Lactones/pharmacology , Lactones/therapeutic use , Mast Cells/drug effects , Inflammation Mediators/antagonists & inhibitors , Inflammation Mediators/metabolism , Gastric Mucosa/cytology , Gastric Mucosa/drug effects , Gastric Mucosa/metabolism , Intestinal Mucosa/cytology , Intestinal Mucosa/drug effects , Intestinal Mucosa/immunology , Sesquiterpenes/pharmacology , Sesquiterpenes/therapeutic use
4.
Biocell ; 26(1): 15-24, Apr. 2002.
Article in English | LILACS | ID: lil-335862

ABSTRACT

We examined the presence of estrogen receptors (ER) in vascular mast cells and a possible genomic effect of estrogens on the expression of mast cell (MC) mediators such as chymase, TNF alpha, NOS and IL-10, which are known to affect the course of atherosclerosis. Immunocytochemical detection of mast cell tryptase and the co-localization of ERs in MCs from abdominal aortic vessels from 10 fertile woman, 10 postmenopausal women and 15 men was performed. The genomic expression of IL-10, TNF alpha, and NOS was analyzed by RT-PCR and chymase activity by spectrophotometry after 24 h incubation with 17-beta estradiol (0.2-0.5 ng/mL) in rat purified peritoneal MCs. A similar number of MCs were found in both intima and adventitia layers from men, and fertile and postmenopausal women, while ERs were detected only in the arterial walls from fertile women. The mRNA expressions of IL-10 and TNF alpha, as well as chymase activity, were not affected. A moderate increment of NO and both NOS, and a reduction in TNF alpha cytotoxicity was observed after incubating peritoneal MCs with 17-beta estradiol at a concentration of 0.5 ng/mL. Taken together, these results indicate that vascular MCs express ERs. The data demonstrate that estrogens can directly modify vascular MC activity. This is a novel mechanism of synergistic cooperation for the protective role of estrogens in the genesis of atherosclerosis.


Subject(s)
Humans , Animals , Male , Female , Rats , Arteries , Mast Cells , Receptors, Estrogen/metabolism , Aorta, Abdominal , Arteries , Interleukin-10 , Nitric Oxide Synthase , Rats, Sprague-Dawley , RNA, Messenger , Tumor Necrosis Factor-alpha
5.
Rev. chil. obstet. ginecol ; 55(4): 254-9, 1990. ilus
Article in Spanish | LILACS | ID: lil-98170

ABSTRACT

Se estudió el efecto in vitro de ritodrine (28,7 ng/ml), fenoterol (30,0 ng/ml), verapamil (43 ng/ml), nifedipino (34,6 ng/ml) y sulfato de magnesio (6 meq/lt) sobre la actividad contráctil espontánea y evocada por prostaglandina PGF 2* en cuernos uterinos de ratones con 15 días de gestación. El rango de concentraciones usadas fue cercana a los niveles plasmáticos efectivos alcanzados para cada tocolítico respectivamente. A las dosis señaladas, la actividad contráctil espontánea fue completamente abolida por los tocolíticos investigados. En cambio, las contracciones evocadas por PGF 2* fueron inhibidas solamente por ritodrine, fenoterol y nifedipino. Se discuten posibles mecanismos involucrados en estas interacciones


Subject(s)
Mice , Animals , Female , Tocolytic Agents/pharmacology , In Vitro Techniques , Myometrium/drug effects , Pregnancy/drug effects , Prostaglandins/pharmacology , Uterine Contraction/physiology
SELECTION OF CITATIONS
SEARCH DETAIL